Cold is linked to longevity and the avoidance of diseases of aging.

Published Date: 24 Apr 2023

Germany: One mechanism underlying the rise in has been revealed by a research team at the University of Cologne's CECAD Cluster of Excellence in Aging Research.

Read Full News

Latest News

Retaining APPs: Why One APP Won’t Leave Rheumatology

Clear expectations, mutual respect with physicians, and compensation models all play important roles in retaining advanced practice providers, a physician assistant says.

Pneumonia Tied to Noncommunicable Disease Risk in Adults

Hospitalization for community-acquired pneumonia is linked to an increased risk of developing multiple chronic noncommunicable diseases over 5 years in adults.

Is ‘Spring Fatigue’ Real? Sleep Study Questions It

In a nine-wave online survey of 418 adults over 18 months, researchers find fatigue levels do not fluctuate seasonally — only everyday activity fatigue falls as days lengthen.

Telemedicine Matches Clinic Visits in IIH Care

Remote consults using optical coherence tomography data show high agreement with traditional clinic evaluations for the management of patients with idiopathic intracranial hypertension.

When Medications May Contribute to Cognitive Decline

Medication-related cognitive impairment is common, mimics neurodegenerative disease, increases with polypharmacy, and may be prevented with regular cognitive assessment monitoring.

Access to Mental Health Support ‘Uneven’ for Young Canadians

The need for mental health support services is high in Canada, especially among youth, but many are unable to access the care they need in a timely manner.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Latest News

Clear expectations, mutual respect with physicians, and compensation models all play important roles in retaining advanced practice providers, a physician assistant says.

Hospitalization for community-acquired pneumonia is linked to an increased risk of developing multiple chronic noncommunicable diseases over 5 years in adults.

In a nine-wave online survey of 418 adults over 18 months, researchers find fatigue levels do not fluctuate seasonally — only everyday activity fatigue falls as days lengthen.

Remote consults using optical coherence tomography data show high agreement with traditional clinic evaluations for the management of patients with idiopathic intracranial hypertension.

Medication-related cognitive impairment is common, mimics neurodegenerative disease, increases with polypharmacy, and may be prevented with regular cognitive assessment monitoring.

The need for mental health support services is high in Canada, especially among youth, but many are unable to access the care they need in a timely manner.

News All Time

AHS Recommends Annual Migraine Screening for Girls and Women

A new recommendation from the American Headache Society calls for annual migraine screening as part of preventive care for girls and women — from adolescence through menopause.

Biologics Don’t Promote Respiratory Infections

Reassuring data support the safety of biologics as an option for asthma care.

Biologics, Phototherapy in Psoriasis: Cost-Benefit Compared

A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

Spirituality Linked to Lower Risk for Substance Misuse

Integrating spirituality into patient care might hold potential for substance use prevention and recovery, a new meta-analysis shows.

GSK Gets US FDA Approval for Expanded Use Of RSV Vaccine

British drugmaker GSK said on Friday the U.S. Food and Drug ⁠Administration has expanded the approved age range for its respiratory syncytial virus vaccine, ⁠Arexvy, to...

WHO Confirms 18 Attacks on Healthcare Sites in Iran

The World Health Organization said on Wednesday that it has verified 18 attacks on healthcare centers ⁠in Iran since the start of the U.S. and Israel war on Iran.

How Can First-Year Residents Avoid Clinical Errors?

Experts say that many early residency mistakes stem from structural factors such as workload, supervision, and training environment, rather than from individual performance.

Dry Powder Inhaler May Reduce COPD Exacerbations

In patients with COPD, starting the umeclidinium-vilanterol dry powder inhaler may lower the risk for exacerbations compared with starting glycopyrrolate-formoterol or tiotropium-olodaterol inhalers.

Add-On Vancomycin Taper May Reduce C difficile Recurrence

In patients with a first episode or first recurrence of Clostridioides difficile infection, adding a vancomycin taper after the standard 14-day course may delay or lower the risk for recurrence.

Donna Ockenden to Lead Review of Leeds Maternity Failures

An independent review will examine maternity and neonatal services at Leeds Teaching Hospitals after repeated safety failures.

Tylenol Use Among Women Dropped After Trump Tied It to Autism, Lancet Analysis Shows

Tylenol use among pregnant women fell after U.S. President Donald Trump linked autism to the over-the-counter pain relief medicine, according to an analysis of U.S....

Generic Flovent Approval Expands Options for Asthma

Glenmark Specialty SA has received the FDA’s approval for true generic fluticasone propionate.

ETI Shows Minimal Bone Health Impact in Cystic Fibrosis

Elexacaftor-tezacaftor-ivacaftor combination therapy shows no clinically meaningful improvement in bone health or calcium metabolism in patients with cystic fibrosis, a Danish study shows.

Hospitalists Get Creative to Find Time for Research

Sometimes that may mean carving out an hour here or there during the day and, sometimes, it may mean working on a day off.

Rethinking Osteoarthritis: Inflammation, Metabolism, Repair

Emerging regenerative and cell-based therapies promise cartilage repair, yet most are preclinical or limited by durability and safety — underscoring the need for rigorous stratification.

Jamaica to End Medical Cooperation Program With Cuba

Jamaica will end a medical cooperation program with Cuba, ⁠as the two governments were unable to agree on the terms ⁠for a new arrangement.

Recommended News For You

Report provides global picture of wide inequalities in care for women's cancers

We Can Advance Our Patients' Healing by One Step With 1,000 Paper Cranes.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

Pulled Myeloma Drug Improves Survival in Trial

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.

Prostate Cancer Treatment Associated With Long-Term Complications

Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.

Recommended Articles For You

Hypercoagulable State: Factors that Contribute to Blood Clots  

Tazemetostat: A Promising New Treatment for Cancer 

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment 

Exploring the Causes and Treatment of Granulocytopenia: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Benzene in Cold Med; Male Cancer Death to Rise 93%; Mail-Order Drugs Compromised?

2.

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

3.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

4.

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

5.

Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma

1.

Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer

2.

Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment

3.

Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care

4.

AI-Powered Case Studies in Oncology: Elevating Clinical Influence Through Real-World Data

5.

Cerebrospinal Fluid Metabolite Biomarkers in Central Nervous System Tumor Monitoring: A New Frontier

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Efficient Management of First line ALK-rearranged NSCLC - Part II

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

Managing CNS diseases at the point of diagnosis in ALK + NSCLC

5.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot